No Data
Is PepGen (NASDAQ:PEPG) In A Good Position To Deliver On Growth Plans?
FDA Staff Cuts Are Already Impacting Regulatory Work, Biotech Leaders Warn
PepGen Inc.'s CEO Makes Bold Stock Purchase!
Insider Purchase: President and CEO of $PEPG Buys 41,500 Shares
Express News | PepGen Announces Appointment of Two New Directors to Its Board
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference